Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations

Summary

Piramal Pharma Limited announced a 22.6% reduction in emissions and 41% renewable energy usage, achieving zero USFDA OAI observations in its operations. The company reached lowest-ever Scope 1 and Scope 2 emissions as part of its SBTi-approved decarbonisation strategy.